
Stay up to date with the latest cannabis news, marijuana research, medical studies, legalization developments, industry trends, and scientific discoveries shaping the future of the plant. We cover important stories from across the cannabis world, including new research on THC and CBD, emerging medical applications, changes in marijuana laws and regulations, business and market developments, cultivation advances, and major findings from universities, researchers, and health organizations. Whether you are interested in cannabis science, medical marijuana, legalization, growing technology, or the evolving cannabis industry, our news coverage helps you understand the developments that matter and the research behind them.
LATEST CANNABIS NEWS
- Massachusetts Freezes New Marijuana Grow Licenses Until June 2027 Amid Cannabis Market ConcernsMassachusetts marijuana regulators are extending a freeze on most new commercial cannabis cultivation licenses through June 30, 2027, as the state attempts to stabilize a legal market struggling with falling marijuana prices, business failures and concerns that growers can already produce more cannabis than… Read more: Massachusetts Freezes New Marijuana Grow Licenses Until June 2027 Amid Cannabis Market Concerns
- Colorado Issues Expanded Marijuana Vape Safety WarningColorado marijuana regulators have dramatically expanded a statewide health and safety warning involving cannabis vape cartridges and disposable devices after investigators identified additional products made with potentially unsafe ingredients. The updated advisory now covers affected Craft-branded marijuana vapes sold at 504 licensed stores across… Read more: Colorado Issues Expanded Marijuana Vape Safety Warning
- New York Approves Phase 3 THC Clinical Trial to Test Cannabis Medicine for Chronic Sciatica PainNew York regulators have approved a cannabis research license that will allow a clinical research center near Buffalo to participate in a large Phase 3 trial testing a standardized THC-containing cannabis medicine for chronic sciatica pain. The approval gives Upstate Clinical Research Associates in… Read more: New York Approves Phase 3 THC Clinical Trial to Test Cannabis Medicine for Chronic Sciatica Pain
- Massachusetts Could Repeal Recreational Marijuana Sales as $10 Billion Cannabis Market Faces November VoteMassachusetts voters are preparing to decide one of the most consequential marijuana ballot measures since the state legalized recreational cannabis a decade ago. Question 8, appearing on the November 3, 2026 statewide ballot, would shut down the regulated adult-use marijuana retail system while preserving… Read more: Massachusetts Could Repeal Recreational Marijuana Sales as $10 Billion Cannabis Market Faces November Vote
- CBN Sleep Aid Shows Signs of THC-Like Dependence in New Cannabis StudyCannabinol, better known as CBN, has rapidly become one of the medicinal cannabis industry’s most popular ingredients for nighttime gummies, tinctures and capsules. Frequently marketed as the “sleepy cannabinoid,” CBN is often positioned as a gentler alternative to THC for consumers who want help… Read more: CBN Sleep Aid Shows Signs of THC-Like Dependence in New Cannabis Study
- DEA Opens Federal Registration for Medical Marijuana Manufacturers, Distributors and Testing LabsThe Drug Enforcement Administration has opened a new federal registration pathway for state-licensed medical marijuana manufacturers, distributors and analytical laboratories, marking another major step in the government’s implementation of Schedule III rules for medical cannabis. The DEA’s Diversion Control Division activated the new application… Read more: DEA Opens Federal Registration for Medical Marijuana Manufacturers, Distributors and Testing Labs
- DEA Says No Marijuana Overdose Deaths Have Been Reported in Updated 2026 Drug GuideThe Drug Enforcement Administration has reaffirmed an unusual fact about marijuana in its updated 2026 drug education materials: the federal agency says no deaths from an overdose of marijuana have been reported. The statement appears in the marijuana section of the DEA’s Drugs of… Read more: DEA Says No Marijuana Overdose Deaths Have Been Reported in Updated 2026 Drug Guide
- Florida Activists Launch Two New Marijuana Legalization Initiatives for 2028 BallotFlorida’s long-running battle over recreational marijuana legalization is entering a new phase, with activists launching two separate constitutional amendment initiatives aimed at putting adult-use cannabis before voters in 2028. The proposals, filed by political committees Floridians for Marijuana and Let Florida Vote IV, would… Read more: Florida Activists Launch Two New Marijuana Legalization Initiatives for 2028 Ballot
- Europe Moves Toward First Major CBD Food Approval as EFSA Clears Synthetic Cannabidiol Safety ReviewEurope has moved significantly closer to authorizing a cannabidiol product as a conventional food supplement after the European Food Safety Authority issued a positive safety opinion for a highly purified form of synthetic CBD. The decision represents one of the most important regulatory developments… Read more: Europe Moves Toward First Major CBD Food Approval as EFSA Clears Synthetic Cannabidiol Safety Review
- IRS and Treasury Move to Clarify Marijuana Tax Rules After Schedule III ChangeThe Internal Revenue Service and U.S. Department of the Treasury are preparing long-awaited guidance on how federal marijuana tax rules should operate after the government moved qualifying medical cannabis into Schedule III. The issue has now been formally added to Treasury and the IRS’s… Read more: IRS and Treasury Move to Clarify Marijuana Tax Rules After Schedule III Change
MARIJUANA NEWS ARCHIVES
- Massachusetts Freezes New Marijuana Grow Licenses Until June 2027 Amid Cannabis Market Concerns
- Colorado Issues Expanded Marijuana Vape Safety Warning
- New York Approves Phase 3 THC Clinical Trial to Test Cannabis Medicine for Chronic Sciatica Pain
- Massachusetts Could Repeal Recreational Marijuana Sales as $10 Billion Cannabis Market Faces November Vote
- CBN Sleep Aid Shows Signs of THC-Like Dependence in New Cannabis Study
- DEA Opens Federal Registration for Medical Marijuana Manufacturers, Distributors and Testing Labs
- DEA Says No Marijuana Overdose Deaths Have Been Reported in Updated 2026 Drug Guide
- Florida Activists Launch Two New Marijuana Legalization Initiatives for 2028 Ballot
- Europe Moves Toward First Major CBD Food Approval as EFSA Clears Synthetic Cannabidiol Safety Review
- IRS and Treasury Move to Clarify Marijuana Tax Rules After Schedule III Change
- Federal Hemp THC Ban Could Eliminate Thousands of Products and 225,000 Jobs
- Medical Marijuana Linked to Reduced Anxiety and Depression in Autistic Patients, Large Minnesota Study Finds
- Medical Marijuana Laws Linked to Reduced Opioid Prescribing for Veterans With Chronic Pain, New Study Finds
- DEA Judge Pauses Marijuana Rescheduling as Watchdog Report Raises Questions About Federal Procedures
- Medical Marijuana Improves Pain, Nausea and Quality of Life for Cancer Patients, New Study Finds
- California Tightens Marijuana Testing Rules and Gives Consumers Access to Cannabis Lab Results
- Colorado Warns Marijuana Vapes Sold at 405 Dispensaries May Contain Hazardous Solvent
- Pennsylvania Senate Reopens Marijuana Legalization Debate as Neighboring States Approach $5 Billion in Sales
- Massachusetts Governor Proposes Expanded Medical Marijuana Access for Veterans
- Federal Watchdog Finds Gaps in DEA and FDA Drug-Scheduling Process Amid Marijuana Rescheduling
- Teen Marijuana Use Falls to Record Low as More States Legalize Cannabis
- Australian THC-Free CBD Pain Tablet Seeks TGA Approval After Phase 3 Trial
- Virginia Unveils Rules for Recreational Marijuana Sales Ahead of 2027 Launch
- Alabama Withdraws Objection to Marijuana Rescheduling as Medical Cannabis Program Takes Off
- New Federal Bill Would Protect Past Marijuana Users Seeking Government Jobs and Security Clearances
- California Pulls Cannabis From Shelves After Worker Death Exposes Pesticide and Safety Concerns at Massive Licensed Farm
- 10-Year Medical Cannabis Study Finds Nearly 90% Drop in Opioid Use Among Chronic Back Pain Patients
- Medical Marijuana Helps Cancer Patients With Pain, Nausea and Sleep in Major 6,621-Patient Study
- Federal Appeals Court Overturns $31.8 Million Marijuana Verdict, Says Cannabis Contract Was Federally Illegal
- Frequent Cannabis Use Linked to Higher THC Levels in Breast Milk
- Federal Appeals Court Rejects Attempt to Block Marijuana Schedule III Order
- Nebraska Supreme Court Unanimously Upholds Voter-Approved Medical Marijuana Laws
- Trump Signs Federal Hemp THC Ban Delay Into Law, Pushing Deadline to December
- Congress Passes Delay of Federal Hemp THC Ban, Sending Bill to Trump
- House Set to Vote on Delaying Federal Hemp THC Ban as Congress Weighs New Regulations
- Federally Funded Study Finds Cancer Patients Report Pain, Sleep and Medication Benefits From Medical Cannabis
- DEA Begins Detailed Inspections of Medical Marijuana Businesses Under New Schedule III Framework
- CBD-Dominant Cannabis Oil May Reduce Chronic Pain After Knee Replacement, New Randomized Trial Finds
- CBD May Increase THC Levels in the Body, Major Meta-Analysis Finds
- CBD Reduces OCD Symptoms in Randomized Placebo-Controlled Clinical Trial
- CBD Matches Codeine-Acetaminophen for Pain After Laser Eye Surgery in Randomized Clinical Trial
- Inhaled Cannabis Linked to Fewer Premature Heartbeats in Surprising Randomized Heart Study
- Cannabis-Derived NTI164 Improves Autism Symptoms in Randomized Pediatric Trial
- FDA Grants Breakthrough Therapy Status to Cannabis-Derived VER-01 for Chronic Back Pain
- WNBA Removes Marijuana From Banned Substances List Under New CBA
- House-Approved Funding Bill Would Allow VA Doctors to Recommend Medical Cannabis to Veterans
- Cannabis Drug Companies Eye IPOs as U.S. Reclassification Fuels Investor Surge
- Scientists Discover Rare Flavoalkaloids with Medical Potential in Cannabis Leaves
- DOJ Moves to Reschedule Medical Cannabis to Schedule III, Triggering Major Regulatory Shift
- Trump Signs Executive Order to Fast-Track Psychedelic Research for Mental Health Treatment
- Alabama Prepares to Open Its First Medical Cannabis Dispensary Next Month
- Federally Funded Study Unveils Marijuana Breathalyzer Breakthrough Using 3D-Printed Roadside Device
- The CLIMB Act: A Bipartisan Push to Unlock Capital for the U.S. Cannabis Industry
- Texas Ban on Selling Smokable Cannabis Takes Effect March 31










